Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 965 studies with search of: | United States, New Hampshire |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
|
||||
2 | Active, not recruiting |
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
|
||||
3 | Recruiting |
Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
|
||||
4 | Recruiting |
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
|
||||
5 | Recruiting |
Combination Chemotherapy in Treating Women With Breast Cancer
|
||||
6 | Recruiting |
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
|
||||
7 | Active, not recruiting |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
|
||||
8 | Active, not recruiting |
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
|
||||
9 | Recruiting |
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
|
||||
10 | Recruiting |
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
|
||||
11 | Active, not recruiting |
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
|
||||
12 | Recruiting |
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
|
||||
13 | Recruiting |
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
|
||||
14 | Recruiting |
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
|
||||
15 | Recruiting |
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
|
||||
16 | Active, not recruiting |
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
|
||||
17 | Recruiting |
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
|
||||
18 | Recruiting |
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
|
||||
19 | Active, not recruiting |
Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
|
||||
20 | Suspended |
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |